nach oben

memo - Magazine of European Medical Oncology

Erschienen in:

01.05.2024 | editorial

Rare lung cancer special: a multifaceted approach

verfasst von: Ass. Prof. PD. Dr. Andreas Pircher, PhD

Erschienen in: memo - Magazine of European Medical Oncology | Ausgabe 2/2024

Einloggen, um Zugang zu erhalten

Excerpt

In the diagnostic and treatment landscape of lung cancers, rare tumors represent a major challenge for patient management in terms of their biology, classification, clinical behavior. Here we present five articles that collectively illustrate the complexity of rare lung cancer subtypes, diagnosis and personalized treatment approaches. …

Vorheriger Artikel Congress update 2023—ASCO and ESMO

Nächster Artikel Antibody–drug conjugates (ADC special)—part 1

Wang C, Zhang R, Xiaorong S, Xing XSL. Prediction of epidermal growth factor receptor mutation status by textural features in stage IV lung adenocarcinoma. memo. 2024;17(2):961–961. https://doi.org/10.1007/s12254-024.CrossRef

Müser NR, Kirchbacher K, Funk G‑C. Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report. memo. 2024;17(2):953–7. https://doi.org/10.1007/s12254-023.CrossRef

Olteanu GE, Brcic L. Pulmonary Puzzles: Salivary Gland-Type Tumors of the Lung and Their Metastatic. memo. 2024;17(2):957–953. https://doi.org/10.1007/s12254-023.CrossRef

Sharapova Y, Loges S, Janning M. Rare oncogenic alterations in NSCLC – focus on atypical EGFR mutations. memo. 2024;17(2):960–2. https://doi.org/10.1007/s12254-024.CrossRef

Heidenreich A, Pfaffenholz P, Pfister D. Diagnosis and Management of mediastinal extragonadal germ cell tumors. memo. 2024; https://doi.org/10.1007/s12254-023-00941-x.CrossRef

Titel: Rare lung cancer special: a multifaceted approach
verfasst von: Ass. Prof. PD. Dr. Andreas Pircher, PhD
Publikationsdatum: 01.05.2024
Verlag: Springer Vienna
Erschienen in: memo - Magazine of European Medical Oncology / Ausgabe 2/2024
Print ISSN: 1865-5041
Elektronische ISSN: 1865-5076
DOI: https://doi.org/10.1007/s12254-024-00970-0

Treatment-changing news in urogenital cancer—a brief unstructured narrative review based on findings presented at the ESMO 2023 conference

Open Access
short review

Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations

Open Access
short review

Antibody–drug conjugates (ADC special)—part 1

editorial

Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

case report

Brief update on systemic therapies in myeloproliferative neoplasms

Open Access
short review

Diagnosis and management of mediastinal extragonadal germ cell tumors

Open Access
short review

Springer Medizin Österreich

Rare lung cancer special: a multifaceted approach

Excerpt

Weitere Artikel der Ausgabe 2/2024

Treatment-changing news in urogenital cancer—a brief unstructured narrative review based on findings presented at the ESMO 2023 conference

Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations

Antibody–drug conjugates (ADC special)—part 1

Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

Brief update on systemic therapies in myeloproliferative neoplasms

Diagnosis and management of mediastinal extragonadal germ cell tumors

Springer Medizin Österreich

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Treatment-changing news in urogenital cancer—a brief unstructured narrative review based on findings presented at the ESMO 2023 conference

Rare oncogenic alterations in NSCLC—focus on atypical EGFR mutations

Antibody–drug conjugates (ADC special)—part 1

Transformation of epidermal growth factor receptor-mutated non-small cell lung cancer into small cell lung cancer—case report

Brief update on systemic therapies in myeloproliferative neoplasms

Diagnosis and management of mediastinal extragonadal germ cell tumors